1. Synthesis and characterization of mesogenic alkyl O-glycosides and their drug release studies
   Saliha Nazir et al, 2023, Journal of Molecular Liquids CrossRef
2. Low-dose aspirin in the primary prevention of cardiovascular diseases: A retrospective, propensity score matched study
   Seong Pyo Kim et al, 2023, Atherosclerosis CrossRef
3. Drug repurposing—an emerging strategy in cancer therapeutics
   Khadija Shahab Turabi et al, 2022, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
4. Safety of surfactant excipients in oral drug formulations
   Sam Maher et al, 2023, Advanced Drug Delivery Reviews CrossRef
5. Remotely controlled electro-responsive on-demand nanotherapy based on amine-modified graphene oxide for synergistic dual drug delivery
   D. Sahoo et al, 2022, Materials Today Chemistry CrossRef
6. Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation
   Dominick J. Angiolillo et al, 2022, Clinical Pharmacokinetics CrossRef
7. An Integrated Strategy of Chemical Fingerprint and Network Pharmacology for the Discovery of Efficacy-Related Q-Markers of Pheretima
   Ye Shang et al, 2022, International Journal of Analytical Chemistry CrossRef
8. Aspirin prescribing pattern and guidelines-adherence evaluation for primary prevention of cardiovascular diseases at a teaching hospital
   Salman Almalki et al, 2021, Saudi Pharmaceutical Journal CrossRef
9. A new triazolothiadiazine derivative inhibits stemness and induces cell death in HCC by oxidative stress dependent JNK pathway activation
   Deniz Cansen Kahraman et al, 2022, Scientific Reports CrossRef
10. Prophylactic aspirin intake and breast cancer risk; A systematic review and meta-analysis of observational cohort studies
    Martyna Bakierzynska et al, 2023, European Journal of Surgical Oncology CrossRef
11. Study on the effect and mechanism of Lacticaseibacillus rhamnosus AFY06 on inflammation-associated colorectal cancer induced by AOM/DSS in mice
    Jing Zhang et al, 2024, Frontiers in Microbiology CrossRef
12. Aspirin Caused Intestinal Damage through FXR and ET-1 Signaling Pathways
    Qiuxia Lin et al, 2024, International Journal of Molecular Sciences CrossRef
13. Long-term aspirin intervention can inhibit TIGIT, regulating T cells to reverse damage to intestines
    Xiaojuan Yang et al, 2021, Biomedicine & Pharmacotherapy CrossRef
14. Current update on herbal sources of antithrombotic activity—a comprehensive review
    Bhavani Subramani et al, 2022, The Egyptian Journal of Internal Medicine CrossRef
15. Emerging Trends and their Impacts on Peptic Ulcer Diseases: Treatments and Techniques
    Pranjal Kumar Singh et al, 2022, Current Drug Therapy CrossRef
16. Crushing tablets or sprinkling capsules: Implications for clinical strategy and study performance based on BE studies of rivaroxaban and deferasirox
    Jan Sus et al, 2024, Clinical and Translational Science CrossRef
17. P2Y12 Inhibitor Monotherapy after Percutaneous Coronary Intervention
    Xuan Zhou et al, 2022, Journal of Cardiovascular Development and Disease CrossRef
18. Design of spherical agglomerates via crystallization with a non-toxic bridging liquid: From mechanism to application
    Shilin Guo et al, 2022, Powder Technology CrossRef